| scholarly article | Q13442814 |
| P50 | author | Aniruddha Roy | Q84042462 |
| P2093 | author name string | Shyh-Dar Li | |
| P2860 | cites work | Using anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancer | Q82203646 |
| Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri | Q84593185 | ||
| Cancer stem cells | Q84976114 | ||
| Polyelectrolyte Multilayers Assembled Entirely from Immune Signals on Gold Nanoparticle Templates Promote Antigen-Specific T Cell Response | Q85278186 | ||
| Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature | Q40388042 | ||
| Penetration of endothelial cell coated multicellular tumor spheroids by iron oxide nanoparticles | Q40578734 | ||
| Modulation of tumor cell response to chemotherapy by the organ environment | Q40630947 | ||
| Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction | Q40964604 | ||
| Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation | Q42117985 | ||
| Integrins in tumor angiogenesis and lymphangiogenesis | Q42263292 | ||
| Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature | Q43201316 | ||
| Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel | Q43287891 | ||
| Tumor regression by targeted gene delivery to the neovasculature | Q44044889 | ||
| Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery | Q44801047 | ||
| CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma. | Q45878473 | ||
| Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma | Q45952675 | ||
| CD133+CD44+ population efficiently enriches colon cancer initiating cells | Q46457938 | ||
| Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging | Q46789795 | ||
| The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel. | Q51797622 | ||
| Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. | Q54327891 | ||
| Molecular interactions of the intrinsic activation complex of coagulation: binding of native and activated human factors IX and X to defined phospholipid vesicles | Q68813838 | ||
| Plasma cortisol and testosterone in hypercholesterolaemia treated with clofibrate and lovastatin | Q69541813 | ||
| Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models | Q73365474 | ||
| Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles | Q74280205 | ||
| SPARC inhibits endothelial cell adhesion but not proliferation through a tyrosine phosphorylation-dependent pathway | Q77123766 | ||
| Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy | Q79286234 | ||
| Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma | Q79600998 | ||
| Nanotechnology-mediated targeting of tumor angiogenesis | Q21195857 | ||
| Salinomycin as a drug for targeting human cancer stem cells | Q21285139 | ||
| Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties | Q22254194 | ||
| ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome | Q24657877 | ||
| Prospective identification of tumorigenic breast cancer cells | Q24683474 | ||
| Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy | Q26782566 | ||
| Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis | Q26866144 | ||
| Tensional homeostasis and the malignant phenotype | Q27860932 | ||
| Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing | Q28131793 | ||
| Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes | Q28384090 | ||
| Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells | Q28481351 | ||
| Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion | Q29547317 | ||
| The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited | Q29547915 | ||
| Role of angiogenesis in tumor growth and metastasis | Q29614309 | ||
| Integrins in cancer: biological implications and therapeutic opportunities | Q29614536 | ||
| Microenvironmental regulation of tumor progression and metastasis | Q29615504 | ||
| Macrophage diversity enhances tumor progression and metastasis | Q29615847 | ||
| The extracellular matrix: a dynamic niche in cancer progression | Q29617793 | ||
| Stromal fibroblasts in cancer initiation and progression | Q29618873 | ||
| Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy | Q30488702 | ||
| Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers | Q30542073 | ||
| Vascular targeted single-walled carbon nanotubes for near-infrared light therapy of cancer | Q31033802 | ||
| Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells | Q33349898 | ||
| A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7 | Q33583613 | ||
| Cancer associated fibroblasts in cancer pathogenesis | Q33664004 | ||
| pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides | Q33703757 | ||
| Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery | Q33836864 | ||
| Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. | Q34164197 | ||
| Chemotherapy enhances cross-presentation of nuclear tumor antigens | Q34226903 | ||
| F3-Targeted Cisplatin-Hydrogel Nanoparticles as an Effective Therapeutic That Targets Both Murine and Human Ovarian Tumor Endothelial Cells In vivo | Q34268119 | ||
| Tumor associated macrophages and neutrophils in tumor progression | Q34306107 | ||
| Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts | Q34358613 | ||
| Distinct fibroblast lineages determine dermal architecture in skin development and repair. | Q34391786 | ||
| TLR-based immune adjuvants. | Q34400322 | ||
| iTEP nanoparticle-delivered salinomycin displays an enhanced toxicity to cancer stem cells in orthotopic breast tumors. | Q34435742 | ||
| Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma | Q34570747 | ||
| Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. | Q34798776 | ||
| TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway | Q35220395 | ||
| Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle | Q35537413 | ||
| Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression. | Q35538088 | ||
| Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. | Q35582297 | ||
| Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells | Q35624160 | ||
| Docetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanism | Q35642480 | ||
| Differential macrophage programming in the tumor microenvironment | Q35803027 | ||
| SPARC and tumor growth: where the seed meets the soil? | Q35813979 | ||
| In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene | Q35854802 | ||
| In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene | Q35856996 | ||
| Cancer stem cells: impact, heterogeneity, and uncertainty | Q35857599 | ||
| Nanoparticle and targeted systems for cancer therapy | Q35879221 | ||
| Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin | Q36217643 | ||
| ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix | Q36324827 | ||
| Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels | Q36324866 | ||
| Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer-Associated Fibroblast Activation. | Q36531166 | ||
| The effect of combined IL10 siRNA and CpG ODN as pathogen-mimicking microparticles on Th1/Th2 cytokine balance in dendritic cells and protective immunity against B cell lymphoma | Q36561226 | ||
| Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch | Q36576720 | ||
| Tumor microenvironment: the role of the tumor stroma in cancer | Q36709404 | ||
| Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis | Q36756947 | ||
| TLR agonists: our best frenemy in cancer immunotherapy | Q36850457 | ||
| Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells | Q37139993 | ||
| Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity. | Q37207049 | ||
| Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug | Q37356199 | ||
| Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose. | Q37377550 | ||
| Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation | Q37483316 | ||
| Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae | Q37612705 | ||
| Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles | Q37624646 | ||
| Differential ability of surface and endosomal TLRs to induce CD8 T cell responses in vivo | Q37728326 | ||
| Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment | Q37731681 | ||
| Tumor angiogenesis: molecular pathways and therapeutic targets | Q37953773 | ||
| Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression | Q37958688 | ||
| RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis | Q38042484 | ||
| Application of polymeric nanoparticles in immunotherapy | Q38055332 | ||
| Tumor-associated macrophages: functional diversity, clinical significance, and open questions | Q38105286 | ||
| Tumor-associated macrophages as major players in the tumor microenvironment | Q38240110 | ||
| Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery | Q38333122 | ||
| Docetaxel conjugate nanoparticles that target α-smooth muscle actin-expressing stromal cells suppress breast cancer metastasis. | Q38453301 | ||
| Emerging therapies: angiogenesis inhibitors for ovarian cancer | Q38497958 | ||
| Nanoparticulate immunotherapy for cancer | Q38598181 | ||
| Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy. | Q38841311 | ||
| Effect of Fe3O4 Nanoparticles on Skin Tumor Cells and Dermal Fibroblasts. | Q38862293 | ||
| CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancer. | Q38891812 | ||
| In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model | Q38931309 | ||
| Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells | Q38934297 | ||
| Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells. | Q38935837 | ||
| Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model | Q39200561 | ||
| F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery | Q39245838 | ||
| Anticancer and immunostimulatory activity by conjugate of paclitaxel and non-toxic derivative of LPS for combined chemo-immunotherapy. | Q39356108 | ||
| A polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonists | Q39452730 | ||
| Synthetic modification of carboxymethylcellulose and use thereof to prepare a nanoparticle forming conjugate of docetaxel for enhanced cytotoxicity against cancer cells. | Q39455442 | ||
| "Click" conjugation of peptide on the surface of polymeric nanoparticles for targeting tumor angiogenesis | Q39581550 | ||
| Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions. | Q39602327 | ||
| Self-assembly nanoparticles for the delivery of bisphosphonates into tumors | Q39635176 | ||
| Combined chemo-immunotherapy as a prospective strategy to combat cancer: a nanoparticle based approach. | Q39658753 | ||
| New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study | Q39730658 | ||
| Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect | Q39754791 | ||
| A novel DDS strategy, "dual-targeting", and its application for antineovascular therapy | Q39823596 | ||
| Identification of gastric cancer stem cells using the cell surface marker CD44. | Q39856772 | ||
| MR imaging of tumor angiogenesis using sterically stabilized Gd-DTPA liposomes targeted to CD105. | Q39973836 | ||
| Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft | Q40140782 | ||
| P433 | issue | 6 | |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 891-908 | |
| P577 | publication date | 2016-04-01 | |
| P1433 | published in | Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology | Q24056192 |
| P1476 | title | Modifying the tumor microenvironment using nanoparticle therapeutics | |
| P478 | volume | 8 |
| Q47417419 | Autonomous self-navigating drug-delivery vehicles: from science fiction to reality |
| Q64086221 | Cell membrane protein functionalization of nanoparticles as a new tumor-targeting strategy |
| Q92592099 | Nanoparticle Interactions with the Tumor Microenvironment |
| Q98771756 | Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy |
Search more.